Granata Bio

About:

Fertility Biotechnology

Top Investors: Alumni Ventures, Google Ventures, What If Ventures, Vibe Bio, Green D Ventures

Description:

Granata Bio is a biotechnology focused on identifying and developing therapeutics for fertility patients. Founded in 2018, the Company recently announced a partnership with IBSA Institut Biochimique (Lugano CH) to co-develop a novel subcutaneous progesterone solution.

Total Funding Amount:

$14.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Duxbury, Massachusetts, United States

Founded Date:

2018-05-01

Contact Email:

info(AT)granata.bio

Founders:

David Paller, Evan Sussman, Marc Chung, Sarah Faranda

Number of Employees:

1-10

Last Funding Date:

2024-01-16

IPO Status:

Private

Industries: